Stock Analiz

Afya Ltd AFYA

Other Consumer Services · IPO 2019 · data as of November 13, 2026

$10.32Market cap $967M
Open the interactive analysis →

Afya Ltd (AFYA) is a real estate company listed in the US with a market value of about $967M. In the twelve months to September 30, 2026 it had revenue of $685M and net income of $140M, a net margin of 20.4%.

Its overall Stock Analiz score is 4.4 out of 5 (excellent). The strongest part is value (5/5); the weakest is shareholder returns (3/5).

Key numbers: a P/E of 6.7, a price to free cash flow of 3.9, 5-year revenue growth of 24% a year, a 5-year average ROIC of 13%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 120% above the current price.

About Afya

Afya is listed in the US and classified in other consumer services, IPO year 2019. Revenue went from $65M in 2017 to $675M in 2025, growth of about 33.9% a year. It was profitable in 9 of the last 9 years in our data.

Score: 4.4 / 5

Value5/5
Future growth5/5
Track record5/5
Financial health4/5
Shareholder returns3/5

Checks passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Checks not passed

  • More cash than debt, or low debt to equity
  • Share count down over 3 years (buybacks)
  • 20% to 100% of free cash flow returned to shareholders

Valuation

P/E (TTM)6.7
Forward P/E5.1
P/FCF3.9
P/S1.4
P/B1.1
EV/EBITDA4.6
PEG0.33
Dividend yield6.36%
FCF yield25.8%
Shareholder yield6.4%
Intrinsic value vs. price+120%

Growth and quality

Revenue growth (1 yr)26.3%
Revenue growth (5 yrs, per year)23.9%
EPS growth (5 yrs, per year)20.2%
FCF growth (3 yrs, per year)24.9%
Net margin (5-yr avg.)16.4%
ROIC (5-yr avg.)12.7%
Profitable years (of last 10)9
Years paying a dividend9

Financials, last 9 years

Fiscal yearTTM202520242023202220212020201920182017
Revenue$685M$675M$534M$593M$441M$309M$231M$187M$86M$65M
Net income$140M$137M$102M$80M$71M$40M$56M$38M$22M$14M
Free cash flow—$249M$210M$191M$128M$91M$54M$60M$16M$7M
EPS (diluted)$1.55$1.47$1.09$0.85$0.75$0.43$0.60$0.41$0.24$0.15
Net margin20.4%20.3%19.1%13.4%16.0%13.0%24.3%20.5%25.9%21.0%
ROIC—13.9%15.0%13.4%12.0%9.0%9.8%8.9%16.0%100.3%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

What is Afya’s P/E ratio?

About 6.7, based on the last twelve months of diluted earnings per share (forward P/E about 5.1).

Is Afya stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 120% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Afya pay a dividend?

Yes. The dividend yield is about 6.36%, and it has paid dividends for 9 years in our data.

Is Afya a good stock to buy?

We do not give buy or sell advice. Afya scores 4.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.